FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2503951330> ?p ?o ?g. }

• W2503951330 endingPage "3394" @default.
• W2503951330 startingPage "3386" @default.
• W2503951330 abstract "Limited data are available evaluating the effects of soy isoflavones on metabolic status of patients with polycystic ovary syndrome (PCOS).The current study was performed to determine the effects of soy isoflavones on metabolic status of patients with PCOS.This randomized, double-blind, placebo-controlled trial was performed on 70 women diagnosed with PCOS according to the Rotterdam criteria who were 18-40 years old. Participants were randomly allocated into two groups to take either 50 mg/d soy isoflavones (n = 35) or placebo (n = 35) for 12 weeks. Metabolic, endocrine, inflammation, and oxidative stress biomarkers were quantified at the beginning of the study and after the 12-week intervention.After 12 weeks of intervention, compared to the placebo group, soy isoflavone administration significantly decreased circulating serum levels of insulin (-1.2 ± 4.0 vs +2.8 ± 4.7 μIU/mL; P < .001) and homeostasis model of assessment-estimated insulin resistance (-0.3 ± 1.0 vs +0.6 ± 1.1; P < .001) and increased the quantitative insulin sensitivity check index (+0.0009 ± 0.01 vs -0.01 ± 0.03; P = .01). Supplementation with soy isoflavones resulted in significant reductions in free androgen index (-0.03 ± 0.04 vs +0.02 ± 0.03; P < .001) and serum triglycerides (-13.3 ± 62.2 vs +10.3 ± 24.5 mg/dL; P = .04) compared to the placebo group. There was a significant increase in plasma total glutathione (+96.0 ± 102.2 vs +22.7 ± 157.8 μmol/L; P = .04) and a significant decrease in malondialdehyde levels (-0.7 ± 0.8 vs +0.8 ± 2.3 μmol/L; P = .001) by soy isoflavone intake compared with the placebo group. We did not observe any significant effect of soy isoflavone intake on other lipid profiles and inflammatory and oxidative stress markers.Soy isoflavone administration for 12 weeks in women with PCOS significantly improved markers of insulin resistance, hormonal status, triglycerides, and biomarkers of oxidative stress." @default.
• W2503951330 created "2016-08-23" @default.
• W2503951330 creator A5001084499 @default.
• W2503951330 creator A5065652905 @default.
• W2503951330 date "2016-09-01" @default.
• W2503951330 modified "2023-10-03" @default.
• W2503951330 title "The Effects of Soy Isoflavones on Metabolic Status of Patients With Polycystic Ovary Syndrome" @default.
• W2503951330 cites W1204135122 @default.
• W2503951330 cites W1483604492 @default.
• W2503951330 cites W1715007658 @default.
• W2503951330 cites W1823276895 @default.
• W2503951330 cites W1839527738 @default.
• W2503951330 cites W1897491882 @default.
• W2503951330 cites W1969137486 @default.
• W2503951330 cites W1973239749 @default.
• W2503951330 cites W1976693936 @default.
• W2503951330 cites W1977085807 @default.
• W2503951330 cites W1977333143 @default.
• W2503951330 cites W1977355560 @default.
• W2503951330 cites W1984073072 @default.
• W2503951330 cites W1986437772 @default.
• W2503951330 cites W1986708956 @default.
• W2503951330 cites W1987862188 @default.
• W2503951330 cites W1996716971 @default.
• W2503951330 cites W2011259601 @default.
• W2503951330 cites W2025564845 @default.
• W2503951330 cites W2028742816 @default.
• W2503951330 cites W2031573286 @default.
• W2503951330 cites W2034274232 @default.
• W2503951330 cites W2045357865 @default.
• W2503951330 cites W2045707228 @default.
• W2503951330 cites W2047370704 @default.
• W2503951330 cites W2047569263 @default.
• W2503951330 cites W2053185870 @default.
• W2503951330 cites W2064285785 @default.
• W2503951330 cites W2064315460 @default.
• W2503951330 cites W2065989691 @default.
• W2503951330 cites W2079932889 @default.
• W2503951330 cites W2084203199 @default.
• W2503951330 cites W2086355819 @default.
• W2503951330 cites W2089362288 @default.
• W2503951330 cites W2089821770 @default.
• W2503951330 cites W2093683863 @default.
• W2503951330 cites W2099383053 @default.
• W2503951330 cites W2099519265 @default.
• W2503951330 cites W2100045361 @default.
• W2503951330 cites W2100478675 @default.
• W2503951330 cites W2102374531 @default.
• W2503951330 cites W2103306043 @default.
• W2503951330 cites W2110260110 @default.
• W2503951330 cites W2110309939 @default.
• W2503951330 cites W2119325245 @default.
• W2503951330 cites W2125032405 @default.
• W2503951330 cites W2127077606 @default.
• W2503951330 cites W2129271656 @default.
• W2503951330 cites W2131457976 @default.
• W2503951330 cites W2135136722 @default.
• W2503951330 cites W2144852094 @default.
• W2503951330 cites W2149979963 @default.
• W2503951330 cites W2151504647 @default.
• W2503951330 cites W2159546734 @default.
• W2503951330 cites W2162695110 @default.
• W2503951330 cites W2163734144 @default.
• W2503951330 cites W2165292984 @default.
• W2503951330 cites W2168987890 @default.
• W2503951330 cites W2169340349 @default.
• W2503951330 cites W2169631253 @default.
• W2503951330 cites W2186218348 @default.
• W2503951330 cites W2418811485 @default.
• W2503951330 cites W838003114 @default.
• W2503951330 cites W877809290 @default.
• W2503951330 doi "https://doi.org/10.1210/jc.2016-1762" @default.
• W2503951330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27490918" @default.
• W2503951330 hasPublicationYear "2016" @default.
• W2503951330 type Work @default.
• W2503951330 sameAs 2503951330 @default.
• W2503951330 citedByCount "53" @default.
• W2503951330 countsByYear W25039513302017 @default.
• W2503951330 countsByYear W25039513302018 @default.
• W2503951330 countsByYear W25039513302019 @default.
• W2503951330 countsByYear W25039513302020 @default.
• W2503951330 countsByYear W25039513302021 @default.
• W2503951330 countsByYear W25039513302022 @default.
• W2503951330 countsByYear W25039513302023 @default.
• W2503951330 crossrefType "journal-article" @default.
• W2503951330 hasAuthorship W2503951330A5001084499 @default.
• W2503951330 hasAuthorship W2503951330A5065652905 @default.
• W2503951330 hasBestOaLocation W25039513301 @default.
• W2503951330 hasConcept C126322002 @default.
• W2503951330 hasConcept C134018914 @default.
• W2503951330 hasConcept C142724271 @default.
• W2503951330 hasConcept C204787440 @default.
• W2503951330 hasConcept C27081682 @default.
• W2503951330 hasConcept C2776151105 @default.
• W2503951330 hasConcept C2777391703 @default.
• W2503951330 hasConcept C2778401633 @default.
• W2503951330 hasConcept C2778901321 @default.
• W2503951330 hasConcept C2779306644 @default.

• next